Journal of Leukemia
Open Access

ISSN: 2329-6917

+44 1300 500008

Journal of Leukemia : Citations & Metrics Report

Articles published in Journal of Leukemia have been cited by esteemed scholars and scientists all around the world. Journal of Leukemia has got h-index 11, which means every article in Journal of Leukemia has got 11 average citations.

Following are the list of articles that have cited the articles published in Journal of Leukemia.

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Total published articles	50	56	62	62	23	11	8	22	23	48	50	29
Research, Review articles and Editorials	38	44	28	40	2	7	7	14	10	24	27	18
Research communications, Review communications, Editorial communications, Case reports and Commentary	12	12	34	22	21	4	1	8	13	24	23	11
Conference proceedings	0	0	0	0	0	0	0	28	0	0	0	0
Citations received as per Google Scholar, other indexing platforms and portals	0	0	0	54	59	64	98	0	74	0	0	0

Journal total citations count	618
Journal impact factor	2.11
Journal 5 years impact factor	3.71
Journal cite score	3.91
Journal h-index	11
Journal h-index since 2019	8

Important citations (462)

BÃ©cue a (2016) emerging fields in fingermark (meta) detectionâ€“a critical review. analytical methods.8:7983-8003. View at Publisher View at Google Scholar
BÃ©cue a (2016)emerging fields in fingermark (meta) detectionâ€“a critical review. analytical methods.8 :7983-8003. View at Publisher View at Google Scholar
Lapierre m, castet-nicolas a, gitenay d, jalaguier s, teyssier c, et al. (2015) expression and role of rip140/nrip1 in chronic lymphocytic leukemia. journal of hematology & oncology.8:20. View at Publisher View at Google Scholar View at Indexing
Xu j, zhou p, wang w, sun a, guo f (2014) relb, together with rela, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow. journal of molecular medicine.92:77-92. View at Publisher View at Google Scholar View at Indexing
Hallermann c, atzpodien j, schulze pd (2010) maligne lymphome der hautÃ¢â?¬â??update zu diagnostik und therapie. best practice onkologie. 25: 4-21. View at Publisher View at Google Scholar View at Indexing
Argudo martÃ?Ânez dc. utilidad de la expresiÃ?Â³n del marcador inmunohistoquimico alk en pacientes con diagnÃ?Â³stico de linfoma no hodgkin (doctoral dissertation, puce). View at Publisher View at Google Scholar View at Indexing
Hallermann c, niermann c, fluck m, fischedick ar, schulze hj, et al. (2011) maligne lymphome der haut. der hautarzt. 62: 947-958. View at Publisher View at Google Scholar View at Indexing
Barth bm, keasey nr, wang x, shanmugavelandy ss, rampal r,et al. (2014)engraftment of human primary acute myeloid leukemia defined by integrated genetic profiling in nod/scid/il2rÎ³null mice for preclinical ceramide-based therapeutic evaluation.j leuk. 2:2. View at Publisher View at Google Scholar
Morad sa, davis ts, kester m, loughran tp, cabot mc, et al.(2015) dynamics of ceramide generation and metabolism in response to fenretinideâ€“diversity within and among leukemia. leukemia research.39:1071-1078. View at Publisher View at Google Scholar
Sun z, wang y, han x, zhao x, peng y, et al.(2015) mir-150 inhibits terminal erythroid proliferation and differentiation. oncotarget.6:43033. View at Publisher View at Google Scholar View at Indexing
Zhang z, zhang t, zhou y, wei x, zhu j, et al.(2015) activated phosphatidylinositol 3-kinase/akt inhibits the transition of endothelial progenitor cells to mesenchymal cells by regulating the forkhead box subgroup o-3a signaling. cellular physiology and biochemistry.35:1643-53. View at Publisher View at Google Scholar View at Indexing
Rochette l, gudjoncik a, guenancia c, zeller m, cottin y,et al. (2015) the iron-regulatory hormone hepcidin: a possible therapeutic target?. pharmacology & therapeutics.28:35-52. View at Publisher View at Google Scholar View at Indexing
Grosicki s. (2014) therapy-related acute myeloid leukemia — the risk factors and treatment. hematologia. 5:136-44. View at Publisher View at Google Scholar View at Indexing
Varella-garcia m, franklin wa, camidge dr. do more with less. View at Publisher View at Google Scholar View at Indexing
Aisner dl, rumery md, merrick dt, kondo kl, et al.(2016) do more with less: tips and techniques for maximizing small biopsy and cytology specimens for molecular and ancillary testing: the university of colorado experience. archives of pathology & laboratory medicine. 140:1206-20. View at Publisher View at Google Scholar View at Indexing
Bubolz am, weissinger se, stenzinger a, arndt a, steinestel k, et al.(2014) potential clinical implications of braf mutations in histiocytic proliferations. oncotarget. 5:4060. View at Publisher View at Google Scholar View at Indexing
Shahjahani m, mohammadiasl j, noroozi f, seghatoleslami m, shahrabi s, et al.(2015) molecular basis of chronic lymphocytic leukemia diagnosis and prognosis. cellular oncology. 38: 93-109. View at Publisher View at Google Scholar
Robak t, robak p (2013) bcr signaling in chronic lymphocytic leukemia and related inhibitors currently in clinical studies. international reviews of immunology.32: 358-376. View at Publisher View at Google Scholar
Ð–Ð¸Ð´ÐµÑ†ÐºÐ¸Ð¹ ÐÐ’. Ð ÐµÑ„Ð¾Ð»Ð´Ð¸Ð½Ð³ Ñ€ÐµÐºÐ¾Ð¼Ð±Ð¸Ð½Ð°Ð½Ñ‚Ð½Ð¾Ð³Ð¾ ÑÐºÑ‚Ð¾Ð´Ð¾Ð¼ÐµÐ½Ð° ÑÑ„Ñ€Ð¸Ð½Ð¾Ð²Ð¾Ð³Ð¾ (2015 Ñ€ÐµÑ†ÐµÐ¿Ñ‚Ð¾Ñ€Ð° Ñ‚Ð¸Ð¿Ð° Ð5. Ð’ Ð¢Ð Ð•Ð¥ Ð§ÐÐ¡Ð¢Ð¯Ð¥.239. View at Publisher View at Google Scholar
Tomasevic n, luehrsen k, baer m, palath v, martinez d, et al.(2014 )a high affinity recombinant antibody to the human epha3 receptor with enhanced adcc activity. growth factors.32:223-35. View at Publisher View at Google Scholar View at Indexing
Prev 1 2 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 Next »

Top